Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Home Print this page Email this page Small font size Default font size Increase font size Users Online: 75
This article has been cited by
1FDA Approved Biologics: Can Etanercept and Ustekinumab be Considered a First-Line Systemic Therapy for Pediatric/Adolescents in Moderate to Severe Psoriasis? A Systematic Review
Nida Aslam,Hajra Saleem,Salikh Murtazaliev,Sohail J Quazi,Safeera Khan
Cureus.2020;()
[DOI]
2Biologics in pediatric dermatology
Manjyot Gautam,Ratnakar Shukla
Indian Journal of Paediatric Dermatology.2021;22(2)107
[DOI]
3Treatment Strategies Against Psoriasis: Principle, Perspectives and Practices
Arya Kadukkattil Ramanunny,Sheetu Wadhwa,Sachin Kumar Singh,Deep Shikha Sharma,Rubiya Khursheed,Ankit Awasthi
Current Drug Delivery.2020;17(1)52
[DOI]
4Psoriasis in Pediatrics
Andrey L. Bakulev,Ekaterina E. Talnikova
Current Pediatrics.2020;19(6)496
[DOI]
Feedback
Subscribe

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal